HemaSource is a distributor of disposable medical products and other medical items used in the blood therapies markets. The company is headquartered in Salt Lake City and serves all 50 states, Puerto Rico, and Canada through its network of distribution centers located in the US (www.hemasource.com).
According to Graham Partners, HemaSource is positioned for growth as a result of increased global demand for plasma-derived products, a recurring revenue stream, and longstanding customer relationships. Additionally, the plasma and plasma-based products industry, which HemaSource serves, is $17 billion in size and has grown 8% per annum over the last four years.
“Graham was attracted to HemaSource’s underlying growth potential driven by an increasing demand for plasma protein therapeutics,” said Josh Wilson, Managing Principal at Graham Partners. “HemaSource has achieved high customer satisfaction due to its compelling software offering and its ongoing effort to co-develop niche products with its largest customers. We look forward to partnering with the company’s strong management team and deploying our operational resources in order to accelerate growth and further drive best practices across all functional areas of the company.”
Graham Partners seeks to acquire companies with EBITDA between $5 million and $50 million, and will invest in smaller companies as add-on acquisitions to existing portfolio companies. The firm is sponsored by the Graham Group, an industrial and investment concern with interests in plastics, packaging, machinery, building products and outsourced manufacturing. Graham Partners was founded in 1988 and is headquartered in Philadelphia (www.grahampartners.net).
“The knowledge and resources Graham Partners brought to the table during the transaction process convinced us they are the right fit as a partner to support HemaSource’s future growth potential,” said Todd Tracey, CEO of HemaSource.
2014 PEPD • Private Equity’s Leading News Magazine • 7-29-14